“…International expert opinion on the use of nebulization for pediatric asthma therapy during the COVID-19 pandemic Guidelines, including those from GINA, recommend the use of pressurized metered dose inhalers (pMDIs) plus a spacer, as an alternative to nebulizers (1)(2)(3)13). However, asthma drug administration by nebulization has many medical benefits compared with administration by pMDI as it allows co-administration of other compatible medications, administration of high doses of medication and furthermore, oxygen could be used as the driving force for nebulization in patients with acute exacerbation and severe hypoxemia (14)(15)(16)(17)(18). Nebulization is also a more user-friendly method compared with drug delivery by pMDI as it requires minimal patient cooperation, does not require patients to hold their breath, permits easy dose adjustments and is straightforward to use (14,19,20).…”